Skip to main content
. 2022 Sep 8;2022:5721167. doi: 10.1155/2022/5721167

Table 3.

Frequency of drug-related adverse effects among patients in each groups.

Number (%)
All (n = 60) Placebo (n = 20) OEA 300 mg/day (n = 20) OEA 600 mg/day (n = 20) P value
Nausea 16 (26.6%) 4 (20%) 6 (30%) 6 (30%) 0.711
Vomiting 11 (18.3%) 3 (15%) 4 (20%) 4 (20%) 0.895
Dyspepsia 24 (40%) 6 (30%) 8 (40%) 10 (50%) 0.435
Headache 26 (43.3%) 7 (35%) 10 (50%) 9 (45%) 0.622
Dizziness 15 (25%) 5 (25%) 5 (25%) 5 (25%) 1.000